Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Celsius Holdings, Inc.CELH · Entity 3658 | Director | February 27, 2026 | March 03, 2026 |
| Niagen Bioscience, Inc.CDXC · Entity 6146 | Director | December 01, 2021 | December 02, 2021 |
| Prenetics Global LtdPRE · Entity 2718 | Director | August 17, 2026 | August 26, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Celsius Holdings, Inc.
Report date February 27, 2026 · Filed March 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, $0.001 par value per shareSEC Table I · non-derivative | Direct | 45,367 |
Reported balance
After 2026-02-27 transaction · row 1
1 source rowRow 1 · 2026-02-27 · Grant · Acquired 2,611 · Balance 45,367 F1: Consists of restricted stock units ("RSUs"), with each RSU providing for the right to receive one share of common stock, par value $0.001 per share, of Celsius Holdings, Inc. The RSUs fully vest on the first anniversary of the grant date. |
Filing footnotes · ownership attribution and instrument terms
F1: Consists of restricted stock units ("RSUs"), with each RSU providing for the right to receive one share of common stock, par value $0.001 per share, of Celsius Holdings, Inc. The RSUs fully vest on the first anniversary of the grant date.
Niagen Bioscience, Inc.
Report date December 01, 2021 · Filed December 02, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $4.53 · Expires 2031-11-30 | Direct | 40,000 |
Reported balance
After 2021-12-01 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2021-12-01 · Grant · Acquired 40,000 · Balance 40,000 F1: The option vests in three substantially equal annual installments beginning on December 1, 2022. |
Filing footnotes · ownership attribution and instrument terms
F1: The option vests in three substantially equal annual installments beginning on December 1, 2022.
Prenetics Global Ltd
Report date August 17, 2026 · Filed August 26, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2033-08-17 | Direct | Not disclosed |
Reported balance
Holding disclosure · report date 2026-08-17 · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · Balance Not disclosed F1: Each Restricted Stock Unit ("RSU"), granted under the Issuer's 2022 Share Incentive Plan, represents a contingent right to receive one Class A Ordinary Share. 7,595 RSUs vest on August 17, 2027, subject to continued service. Upon vesting, the RSUs are settled and delivered in shares. |
Filing footnotes · ownership attribution and instrument terms
F1: Each Restricted Stock Unit ("RSU"), granted under the Issuer's 2022 Share Incentive Plan, represents a contingent right to receive one Class A Ordinary Share. 7,595 RSUs vest on August 17, 2027, subject to continued service. Upon vesting, the RSUs are settled and delivered in shares.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 27, 2026 Filed Mar 3, 2026 18:13 UTC | Celsius Holdings, Inc. CELH · Entity 3658 | GrantCommon Stock, $0.001 par value per share | 2,611 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-014135 · wk-form4_1772579596.xml · nonDerivative · entry 1 Levy Caroline S · CIK 0001820042 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,367 F1 · shares: Consists of restricted stock units ("RSUs"), with each RSU providing for the right to receive one share of common stock, par value $0.001 per share, of Celsius Holdings, Inc. The RSUs fully vest on the first anniversary of the grant date. Read SEC document |
| March 11, 2025 Filed Mar 13, 2025 16:32 UTC | Celsius Holdings, Inc. CELH · Entity 3658 | Exercise / conversionCommon Stock Option · Derivative | 70,000 | $0.00 Strike: $4.84 | $0.00 |
DisclosureSEC source: 0001341766-25-000059 · wk-form4_1741897959.xml · derivative · entry 3 Levy Caroline S · CIK 0001820042 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $0.001 par value per share · 70,000 shares Expires 2025-07-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 11, 2025 Filed Mar 13, 2025 16:32 UTC | Celsius Holdings, Inc. CELH · Entity 3658 | SaleCommon Stock, $0.001 par value per share | 70,000 | $26.84 | $1,878,800.00 |
DisclosureSEC source: 0001341766-25-000059 · wk-form4_1741897959.xml · nonDerivative · entry 2 Levy Caroline S · CIK 0001820042 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,756 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $26.72 to $26.99, inclusive. The reporting person undertakes to provide Celsius Holdings, Inc. ("Celsius"), any security holder of Celsius, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| March 11, 2025 Filed Mar 13, 2025 16:32 UTC | Celsius Holdings, Inc. CELH · Entity 3658 | Exercise / conversionCommon Stock, $0.001 par value per share | 70,000 | $4.84 | $338,800.00 |
DisclosureSEC source: 0001341766-25-000059 · wk-form4_1741897959.xml · nonDerivative · entry 1 Levy Caroline S · CIK 0001820042 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 112,756 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2025 Filed Mar 4, 2025 17:05 UTC | Celsius Holdings, Inc. CELH · Entity 3658 | GrantCommon Stock, $0.001 par value per share | 4,865 | $0.00 | $0.00 |
DisclosureSEC source: 0001341766-25-000035 · wk-form4_1741125941.xml · nonDerivative · entry 1 Levy Caroline S · CIK 0001820042 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,756 F1 · shares: Consists of restricted stock units ("RSUs"), with each RSU providing for the right to receive one share of common stock, par value $0.001 per share, of Celsius Holdings, Inc. The RSUs fully vest on the first anniversary of the grant date. Read SEC document |
| March 13, 2024 Filed Mar 14, 2024 16:48 UTC | Celsius Holdings, Inc. CELH · Entity 3658 | Exercise / conversionCommon Stock Option · Derivative | 20,000 | $0.00 Strike: $4.84 | $0.00 |
DisclosureSEC source: 0001628280-24-011251 · wk-form4_1710449298.xml · derivative · entry 3 Levy Caroline S · CIK 0001820042 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,000 Underlying: Common Stock, $0.001 par value per share · 20,000 shares Expires 2030-07-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 13, 2024 Filed Mar 14, 2024 16:48 UTC | Celsius Holdings, Inc. CELH · Entity 3658 | SaleCommon Stock, $0.001 par value per share | 20,000 | $94.77 | $1,895,400.00 |
DisclosureSEC source: 0001628280-24-011251 · wk-form4_1710449298.xml · nonDerivative · entry 2 Levy Caroline S · CIK 0001820042 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,891 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $94.75 to $94.82, inclusive. The reporting person undertakes to provide Celsius Holdings, Inc. ("Celsius"), any security holder of Celsius, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| March 13, 2024 Filed Mar 14, 2024 16:48 UTC | Celsius Holdings, Inc. CELH · Entity 3658 | Exercise / conversionCommon Stock, $0.001 par value per share | 20,000 | $4.84 | $96,800.00 |
DisclosureSEC source: 0001628280-24-011251 · wk-form4_1710449298.xml · nonDerivative · entry 1 Levy Caroline S · CIK 0001820042 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,891 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 18:02 UTC | Celsius Holdings, Inc. CELH · Entity 3658 | GrantCommon Stock, $0.001 par value per share | 1,576 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-009094 · wk-form4_1709679705.xml · nonDerivative · entry 1 Levy Caroline S · CIK 0001820042 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,891 F1 · security: Consists of restricted stock units ("RSUs"), with each RSU providing for the right to receive one share of common stock, par value $0.001 per share, of Celsius Holdings, Inc. The RSUs vest on the first anniversary of the grant date Read SEC document |
| August 11, 2023 Filed Aug 14, 2023 17:24 UTC | Celsius Holdings, Inc. CELH · Entity 3658 | SaleCommon Stock | 25,000 | $171.67 | $4,291,750.00 |
DisclosureSEC source: 0001628280-23-029452 · wk-form4_1692048237.xml · nonDerivative · entry 2 Levy Caroline S · CIK 0001820042 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,500 Read SEC document |
| August 11, 2023 Filed Aug 14, 2023 17:24 UTC | Celsius Holdings, Inc. CELH · Entity 3658 | SaleCommon Stock | 5,500 | $172.35 | $947,925.00 |
DisclosureSEC source: 0001628280-23-029452 · wk-form4_1692048237.xml · nonDerivative · entry 1 Levy Caroline S · CIK 0001820042 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,500 Read SEC document |
| August 11, 2023 Filed Feb 14, 2024 18:09 UTC | Celsius Holdings, Inc. CELH · Entity 3658 | Exercise / conversionCommon Stock Option · Derivative | 75,000 | $0.00 Strike: $4.83 | $0.00 |
DisclosureSEC source: 0001628280-24-004867 · wk-form5_1707952163.xml · derivative · entry 2 Levy Caroline S · CIK 0001820042 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 90,000 Underlying: Common Stock, $0.001 par value per share · 75,000 shares Expires 2030-07-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Reflects adjustments for the three-for-one stock split that occurred on November 15, 2023. F1 · shares: Reflects adjustments for the three-for-one stock split that occurred on November 15, 2023. F1 · derivative.underlying_shares: Reflects adjustments for the three-for-one stock split that occurred on November 15, 2023. F1 · balance_after: Reflects adjustments for the three-for-one stock split that occurred on November 15, 2023. Read SEC document |
| August 11, 2023 Filed Feb 14, 2024 18:09 UTC | Celsius Holdings, Inc. CELH · Entity 3658 | Exercise / conversionCommon Stock, $0.001 par value per share | 75,000 | $4.83 | $362,250.00 |
DisclosureSEC source: 0001628280-24-004867 · wk-form5_1707952163.xml · nonDerivative · entry 1 Levy Caroline S · CIK 0001820042 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,315 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Reflects adjustments for the three-for-one stock split that occurred on November 15, 2023. F1 · price: Reflects adjustments for the three-for-one stock split that occurred on November 15, 2023. F1 · balance_after: Reflects adjustments for the three-for-one stock split that occurred on November 15, 2023. Read SEC document |
| May 18, 2023 Filed May 25, 2023 21:14 UTC | Celsius Holdings, Inc. CELH · Entity 3658 | SaleCommon Stock | 2,200 | $134.51 | $295,922.00 |
DisclosureSEC source: 0001829126-23-003768 · ownership.xml · nonDerivative · entry 1 Levy Caroline S · CIK 0001820042 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,605 F1 · price: This transaction was executed in multiple trades at prices ranging from $134.50 to $134.61. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4. Read SEC document |
| January 01, 2023 Filed Jan 5, 2023 17:06 UTC | Celsius Holdings, Inc. CELH · Entity 3658 | GrantCommon Stock | 1,105 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001829126-23-000456 · ownership.xml · nonDerivative · entry 1 Levy Caroline S · CIK 0001820042 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,855 F1 · price: The reporting person was granted 1,105 RSUs for shares of common stock to be issued under the Issuer's 2015 Stock Incentive Plan. The RSUs shall vest on January 1, 2024. Read SEC document |
| January 01, 2022 Filed Apr 24, 2023 16:05 UTC | Celsius Holdings, Inc. CELH · Entity 3658 | GrantCommon Stock | 2,200 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001829126-23-002896 · ownership.xml · nonDerivative · entry 2 Levy Caroline S · CIK 0001820042 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,805 F2 · price: Represents a grant of RSUs, all of which vested on December 31, 2022. Read SEC document |
| December 01, 2021 Filed Dec 2, 2021 21:45 UTC | Niagen Bioscience, Inc. CDXC · Entity 6146 | GrantStock Option (right to buy) · Derivative | 40,000 | $0.00 Strike: $4.53 | $0.00 |
DisclosureSEC source: 0001628280-21-024444 · wf-form4_163848152738878.xml · derivative · entry 1 Levy Caroline S · CIK 0001820042 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2031-11-30 F1 · derivative.exercise_date: The option vests in three substantially equal annual installments beginning on December 1, 2022. Read SEC document |
| January 01, 2021 Filed Apr 24, 2023 16:05 UTC | Celsius Holdings, Inc. CELH · Entity 3658 | GrantCommon Stock | 16,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001829126-23-002896 · ownership.xml · nonDerivative · entry 1 Levy Caroline S · CIK 0001820042 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,605 F1 · price: Represents a grant of restricted stock units ("RSUs"), which vest in equal annual installments over a three year period beginning one year from the date of grant, subject to the reporting person's continued services as a director of the issuer. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.